24 Week Safety and Tolerability of Nevirapine Versus Abacavir in Combination with Zidovudine/Lamivudine as First-Line Antiretroviral Therapy: A Randomised Double-Blind Trial (NORA).
Objective: To compare the safety/tolerability of abacavir and nevirapine in HIV-infected adults starting antiretroviral (ARV) therapy in Uganda. Methods: Twenty-four-week randomized double-blind trial conducted with 600 symptomatic ARV-naive adults with CD4
Tropical Medicine & International Health (2008) 13 (1), pp. 6-16 [doi10.111/j.1365-3156.2007.01973.x]